Affordable Access

deepdyve-link
Publisher Website

Safety aspects of lipidapheresis using DALI and MONET - Multicenter observational study.

Authors
  • Kozik-Jaromin, Justyna1
  • Röseler, Eberhard2
  • Heigl, Franz3
  • Spitthöver, Ralf4
  • Ringel, Jens5
  • Schmitz, Gerd6
  • Heinzler, Rainer7
  • Abdul-Rahman, Nadim8
  • Leistikow, Frank9
  • Himmelsbach, Frido10
  • Schettler, Volker11
  • Uhlenbusch-Körwer, Ingrid1
  • Ramlow, Wolfgang12
  • 1 Clinical and Epidemiological Research, Fresenius Medical Care, Daimlerstraße 15, Bad Homburg, Germany. , (Germany)
  • 2 Zentrum für Nieren-, Hochdruck und Stoffwechselerkrankungen, Heidering 31, Hannover, Germany. , (Germany)
  • 3 Dres. Heigl, Hettich & Partner Medizinisches Versorgungszentrum, Robert Weixler-Straße 19, Kempten, Germany. , (Germany)
  • 4 Nephrologische Gemeinschaftspraxis Dialysezentrum/Lipidzentrum Dr. med. Ralf Spitthöver, Dr. med. Johann Knee, Dr. med. Alexandra Gröschel, Hindenburgstraße 27, Essen, Germany. , (Germany)
  • 5 Dialysezentrum Potsdam, Allee nach Sanssouci 7, Potsdam, Germany. , (Germany)
  • 6 Universitätsklinikum Regensburg Institut für Klinische Chemie und Laboratoriumsmedizin, Franz-Josef-Strauß-Allee 11, Regensburg, Germany. , (Germany)
  • 7 Dr. med. Detlef Gysan, Dr- med. Rainer Heinzler, Dr. med. Erik May Fachärzte für Innere Medizin/Kardiologie, Rolshover Straße 526, Köln, Germany. , (Germany)
  • 8 Dialysezentrum Fachpraxis für Nieren-und Hochdruckkrankheiten & Lipid-Apherese, Liebknechtstraße 36a, Magdeburg, Germany. , (Germany)
  • 9 Apherese- und Nierenzentrum Mannheim, Dornheimer Ring 92, Mannheim, Germany. , (Germany)
  • 10 Apheresezentrum Ingelheim, Carolinenstraße 6, Ingelheim, Germany. , (Germany)
  • 11 Nephrologisches Zentrum Göttingen, An der Lutter 24, Göttingen, Germany. , (Germany)
  • 12 Apherese Centrum Rostock (ACR), Nobelstraße 53, Rostock, Germany. Electronic address: [email protected] , (Germany)
Type
Published Article
Journal
Atherosclerosis. Supplements
Publication Date
Nov 01, 2017
Volume
30
Pages
225–231
Identifiers
DOI: 10.1016/j.atherosclerosissup.2017.05.036
PMID: 29096842
Source
Medline
Keywords
License
Unknown

Abstract

Under routine use the frequency of side-effects was low. Still, monitoring of blood count and proteins in chronic apheresis patients is recommended.

Report this publication

Statistics

Seen <100 times